Journal Mobile Options
Table of Contents
Vol. 32, No. 3, 2011
Issue release date: October 2011
Blood Purif 2011;32:161–173
(DOI:10.1159/000325459)

VDR Expression on Circulating Endothelial Progenitor Cells in Dialysis Patients Is Modulated by 25(OH)D Serum Levels and Calcitriol Therapy

Cianciolo G. · La Manna G. · Cappuccilli M.L. · Lanci N. · Della Bella E. · Cuna V. · Dormi A. · Todeschini P. · Donati G. · Alviano F. · Costa R. · Bagnara G.P. · Stefoni S.
aNephrology Dialysis and Renal Transplantation Unit, S. Orsola University Hospital, bDepartment of Medicine and Public Health, and cDepartment of Histology, Embryology and Applied Biology, University of Bologna, Bologna, Italy

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background/Aims: Vitamin D deficiency is associated with endothelial dysfunction in uremic patients, possibly by the impairment in the number and function of endothelial progenitor cells (EPCs). In 89 hemodialysis patients, we investigated the factors associated with the number of circulating EPCs (CD34+/CD133+/KDR+ and CD34+/CD133/KDR+ cells), the presence of VDR and the determinants of VDR expression on EPCs, in particular in calcitriol therapy. Methods: EPC counts, percentages of VDR-positive EPCs and VDR expression were assessed by flow cytometry. Cells isolated from a subgroup of patients were cultured to analyze colony-forming units, specific markers expression and a capillary-like structure formation. Results/Conclusions: Our study demonstrates the presence of VDR on EPCs. In our dialysis patients, the parameters studied on both CD34+/CD133+/KDR+ and CD34+/CD133/KDR+ cells, in particular VDR expression, seem to be influenced by uremia-related factors, including anemia, inflammation, diabetes, 25(OH)D serum levels and calcitriol therapy.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Holick MF: Vitamin D deficiency. N Engl J Med 2007;357:266–281.
  2. Wu-Wong JR: Vitamin D receptor: a highly versatile nuclear receptor. Kidney Int 2007;72:237–239.
  3. Verstuyf A, Carmeliet G, Bouillon R, et al: Vitamin D: a pleiotropic hormone. Kidney Int 2010;78:140–145.
  4. Li YC, Qiao G, Uskokovic M, et al: Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004;89–90:387–392.
  5. Aihara K, Azuma H, Akaike M, et al: Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem 2004;279:35798–35802.
  6. Wu-Wong JR, Nakane M, Ma J, et al: Effects of vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. Atherosclerosis 2006;186:20–28.
  7. Wu-Wong JR, Noonan W, Ma J, et al: Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification. J Pharmacol Exp Ther 2006;318:90–98.
  8. Park CW, Oh YS, Shin YS, et al: Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 1999;33:73–81.
  9. Zehnder D, Bland R, Chana RS, et al: Synthesis of 1,25-dihydroxyvitamin D3 by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol 2002;13:621–629.
  10. Tarcin O, Yavuz DG, Ozben B, et al: Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 2009;94:4023–4030.
  11. Caplan BA, Schwartz CJ: Increased endothelial cell turnover in areas of in vivo Evans Blue uptake in the pig aorta. Atherosclerosis 1973;17:401–417.
  12. Dimmeler S, Zeiher AM: Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? J Mol Med 2004;82:671–677.
  13. Hill JM, Zalos G, Halcox JP, et al: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593–600.
  14. Schmidt-Lucke C, Rössig L, Fichtlscherer S, et al: Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005;111:2981–2987.
  15. Werner N, Kosiol S, Schiegl T, et al: Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353:999–1007.
  16. Herbrig K, Pistrosch F, Oelschlaegel U, et al: Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis. Am J Kidney Dis 2004;44:840–849.
  17. Choi JH, Kim KL, Huh W, et al: Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 2004;24:1246–1252.
  18. Steiner S, Schaller G, Puttinger H, et al: History of cardiovascular disease is associated with endothelial progenitor cells in peritoneal dialysis patients. Am J Kidney Dis 2005;46:520–528.
  19. Tousoulis D, Andreou I, Antoniades C, et al: Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases. Atherosclerosis 2008;201:236–247.
  20. Case J, Mead LE, Bessler WK, et al: Human CD34+AC133+VEGFR2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 2007;35:1109–1118.
  21. Timmermans F, Plum J, Yöder MC, Ingram DA, Vandekerckhove B, Case J: Endothelial progenitor cells: identity defined? J Cell Mol Med 2009;13:87–102.
  22. Rafii S, Lyden D: Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003;9:702–712.
  23. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183–1197.
  24. Agatston AS, Janowitz WR, Hildner FJ, et al: Quantification of coronary artery calcium using UCT. J Am Coll Cardiol 1990;15:827–832.
  25. Araki A, Sako Y: Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:43–52.
  26. Kalantar-Zadeh K, Kuwae N, Regidor DL, et al: Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006;70:771–780.
  27. Tentori F, Hunt WC, Stidley CA, et al: Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 2006;70:1858–1865.
  28. Teng M, Wolf M, Ofsthun MN, et al: Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 2005;16:1115–1125.
  29. Ueno H, Koyama H, Fukumoto S, et al: Dialysis modality is independently associated with circulating endothelial progenitor cells in end-stage renal disease patients. Nephrol Dial Transplant 2010;25:581–586.
  30. Schlieper G, Hristov M, Brandenburg V, et al: Predictors of low circulating endothelial progenitor cell numbers in haemodialysis patients. Nephrol Dial Transplant 2008;23:2611–2618.
  31. De Groot K, Bahlmann FH, Sowa J, et al: Uremia causes endothelial progenitor cell deficiency. Kidney Int 2004;66:641–646.
  32. Fadini GP, Sartore S, Albiero M, et al: Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 2006;26:2140–2146.
  33. Jialal I, Devaraj S, Singh U, et al: Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk. Atherosclerosis 2010;211:297–302.
  34. George J, Goldstein E, Abashidze S, et al: Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur Heart J 2004;25:1003–1008.
  35. Hristov M, Fach C, Becker C, et al: Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis 2007;192:413–420.
  36. Guven H, Shepherd RM, Bach RG, et al: The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol 2006;48:1579–1587.
  37. Caglar K, Yilmaz MI, Saglam M, et al: Endothelial dysfunction and fetuin-A levels before and after kidney transplantation. Transplantation 2007;83:392–397.
  38. Hermans MM, Kooman JP, Brandenburg V, et al: Spatial inhomogeneity of common carotid artery intima-media is increased in dialysis patients. Nephrol Dial Transplant 2007;22:1205–1212.

    External Resources

  39. Bahlmann FH, De Groot K, Spandau JM, et al: Erythropoietin regulates endothelial progenitor cells. Blood 2004;103:921–926.
  40. Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al: Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:18–28.
  41. Dobnig H, Pilz S, Scharnagl H, et al: Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340–1349.
  42. Ravani P, Malberti F, Tripepi G, et al: Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 2009;75:88–95.
  43. Wolf M, Shah A, Gutierrez O, et al: Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007;72:1004–1013.
  44. Stubbs JR, Idiculla A, Slusser J, et al: Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD. Am Soc Nephrol 2010;21:353–361.
  45. Richardson MR, Yoder MC: Endothelial progenitor cells: Quo vadis? J Mol Cell Cardiol 2011;50:266–272.
  46. Alon DB, Chaimovitz C, Dvilansky A, et al: Novel role of 1,25(OH)2D3 in induction of erythroid progenitor cell proliferation. Exp Hematol 2002;30:403–409.
  47. Patel NM, Gutiérrez OM, Andress DL, et al: Vitamin D deficiency and anemia in early chronic kidney disease. Kidney Int 2010;77:715–720.
  48. Jung C, Rafnsson A, Shemyakin A, et al: Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes. Int J Cardiol 2010;143:368–372.

    External Resources

  49. Fadini GP, Sartore S, Schiavon M, et al: Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. Diabetologia 2006;49:3075–3084.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50